[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590739":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":20,"locations":29,"responsibleParty":50,"collaborators":53,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":10,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":10,"enrollmentInfo":66,"targetDuration":10,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":77,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"University of Bologna","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Mycoclear®, medical device as antimycotic topical solution",null,"Mycoclear® was topically administered as indicated in the instructions for use of the product for a maximum of 24 weeks",{"label":13,"type":10,"description":14,"interventionNames":10},"Ciclopirox, antimycotic drug","Ciclopirox was topically administered as indicated in the instructions for use of the product for a maximum of 24 weeks",[16],{"name":17,"affiliation":18,"role":19},"Bianca M Piraccini, Prof PhD MD","Dipartimento di Scienze Mediche e Chirurgiche Alma Mater Studiorum - Università di Bologna","STUDY_DIRECTOR",[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Michela Valeria R Starace, MD PhD","CONTACT","+39 051214 3677","michela.starace2@unibo.it",{"name":27,"role":23,"phone":28,"phoneExt":10,"email":10},"Lucia A Data Manager, Msc","+39 0512143507",[30],{"facility":31,"status":10,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"UOC di Dermatologia - IRCCS Policlinico di Sant'Orsola - Università di Bologna","Bologna","BO","40138","Italy","IT",{"type":38,"coordinates":39},"Point",[40,41],11.33875,44.49381,{"lat":41,"lon":40},[44,47],{"name":45,"role":23,"phone":28,"phoneExt":10,"email":46},"Lucia Abitante, MSc","lucia.abitante2@unibo.it",{"name":48,"role":49,"phone":10,"phoneExt":10,"email":10},"Michela Valeria R Starace, PhD MD","PRINCIPAL_INVESTIGATOR",{"type":49,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Michela Valeria Rita Starace, MD PhD","Full-time Researcher RTD-B",[54],{"name":55,"class":56},"Dionisio Franco Barattini, MD, MBA, MSc","UNKNOWN","100590739","study-in-patients-with-onychomycosis-treated-with-mycoclear-and-ciclopirox-100590739",false,"NCT06971341","Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox","Retrospective Observational Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox","Inclusion Criteria:\n\n* Age ≥ 18 years old.\n* Patients clinically and microscopically KOH diagnosed with distal and lateral subungual onychomycosis (DLSO) (≤30% involvement of the nail plate of at least one of the great toenails) and evaluated as mild to moderate following OSI6.\n* Patients presenting positive direct potassium hydroxide (KOH) microscopy and positive fungal culture for dermatophytes\n\nExclusion Criteria:\n\n* Other types of onychomycoses.\n* Subjects who used systemic antifungal agents within 6 months or topical antifungal agents on toenails within 6 weeks of screening.\n* Pregnant woman, lactating woman.","ALL","18 Years",{"count":67,"type":68},80,"ESTIMATED","OBSERVATIONAL","The goal of this study is to learn about the effectiveness and safety of two products, ciclopirox or Mycoclear®, in treating fungal infections. People with fungal infections of the nails and over the age of 18 were treated at the Department of Dermatology, IRCCS Azienda Ospedaliero - Universitaria Sant'Orsola in Bologna (Italy) between January 1, 2019, and April 30, 2023. The people were treated as part of their regular medical care with ciclopirox or Mycoclear®. In this observational study, the data are now being reviewed to answer the following questions:\n\n• Does Mycoclear® work as well as ciclopirox for fungal nail infections, when used for up to 24 weeks?\n\nPeople were seen at the beginning for an initial assessment, and then again at two, four, 12, and 24 weeks. The doctor did the following main tests during the study period:\n\n* Performing the clinical evaluation\n* Checking the lab test for a fungal infection.\n* Measuring how much of the nail grows without problems. The results of this study will help dermatologists choose the best treatment for fungal nail infections.",[72],"Onychomycosis of Toenails",[74,75,76],"onychomycosis","medical device","observational study","NOT_YET_RECRUITING","2025-05-14",{"date":80,"type":81},"2025-05-20","ACTUAL",{"date":83,"type":68},"2025-05-30",{"date":85,"type":68},"2025-12-30",{"name":5,"class":6},1]